Presentation is loading. Please wait.

Presentation is loading. Please wait.

Aug, 2016.

Similar presentations


Presentation on theme: "Aug, 2016."— Presentation transcript:

1 Aug, 2016

2 Mobile Applications in Warfarin Dose Adjustment
Habibollah Saadat, MD Professor of Cardiology, Modares Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran Aug, 2016

3 Mysterious past Glorious present Challenging future
Aug, 2016

4 sweet smell but bitter taste
Sweet clover sweet smell but bitter taste Systematic Name (RS)-4-hydroxy- 3-(3- oxo- 1-phenylbutyl)- 2H- chromen- 2-aone Aug, 2016

5 Long-Term Oral Anticoagulation The State of the Art
Wisconsin Alumni Research Foundation + Coumarin = WARFARIN 1920 1941 1954 Aug, 2016

6 Reasons for Prescribing Warfarin
Patients need to know why they need to be prescribed warfarin, and the consequences of not taking. The main indications for oral anticoagulation are: Deep Vein Thrombosis Pulmonary Embolism Atrial Fibrillation Mechanical Heart Valves The NPSA recommends when telling patients what warfarin does we use the phrase: “Makes your blood take longer to clot” Consequences include further VTE, stroke and death So as clinicians you need to explain what the diagnosis is and why it is necessary to treat with an anticoagulant Aug, 2016

7 Monitoring Requirements for Warfarin
Patients need to be told the importance of having their INR measured Patients should be made aware of what their INR range is and what it signifies Recommended INRs are: Indication INR range INR target DVT 2 – 3 2.5 PE 2 - 3 Recurrent VTE whilst on warfarin 3 - 4 3.5 AF Mechanical valves Typical target is between 2.5 and 3.5 Aug, 2016

8 Aug, 2016

9 Quality of Warfarin Management in the United States is Poor
Aug, 2016

10 Reference: Aug, 2016

11 2012 National Patient Survey
*30% of patients said they did not have the purpose of their medicines fully explained to them in a way they could understand *60% of patients said they were not fully told about which side effects to watch out for Aug, 2016

12 Monitoring of Warfarin INR Challenges With Conventional Laboratory Testing
Aug, 2016

13 Limitations of Warfarin (VKA)
Anticoagulation Clinics Requires frequent monitoring ? Genotype testing Narrow Therapeutic Index & Drug/Diet Interactions Complicates management of: Bleeding patient Patient with High INR Long Half-Life Slow Onset of Action Heparin “overlap” often necessary Periprocedural Anticoagulation Difficult Aug, 2016

14 Timeline AC management clinics Warfarin become increasingly prevalent
first used POC testing, PST, dosing algorithms, software programs, better understanding of genetics and drug interactions WHO endorses INR 1950’s 1991 1999 1983 Efficacy of VKA to prevent AF-related stroke demonstrated Aug, 2016

15 Aug, 2016

16 Aug, 2016

17 Aug, 2016

18 Aug, 2016

19 Anticoagulation Management Service Can Increase Time-in-Range
% of patients % time in range Aug, 2016 Witt et al. Chest 2005.

20 Anticoagulation Management Services
Resource-intensive Only available to a minority of patients in many countries (including the United States) Aug, 2016

21 Patient Self-Management Reduces Risk of Thromboembolic Events
Similar trend for bleeding… Aug, 2016 Heneghan et al. Lancet Feb 4;367(9508):

22 Why Home Monitoring Achieves Better Outcomes
Aug, 2016

23 Point of care coagulation monitoring
It is estimated that over 10 million people are taking warfarin and more than 200 million PT-INR tests are conducted each year worldwide. The point-of-care coagulation monitoring market is estimated to be worth approximately US$1 billion globally with point-of-care PT-INR testing making up over 65% of this market.   Aug, 2016

24 Point of care coagulation monitoring
Aug, 2016

25 Point of Care Diagnostics
Aug, 2016

26 Benefits of POC INR Monitors
Aug, 2016

27 Aug, 2016

28 Aug, 2016

29 Aug, 2016

30 Aug, 2016

31 Advantages of mobile Apps
Interactivity Personalization Complex Calculations or Reporting. Native Functionality or Processing Required. Internet Connection is Not Always Required. Aug, 2016

32 Aug, 2016

33 Aug, 2016

34 Aug, 2016

35 Conclusions Although Warfarin treatment is safer and more practical than it was years ago, there is certainly room for further improvement Aug, 2016

36 Aug, 2016

37 Aug, 2016

38 Aug, 2016

39 Aug, 2016

40 Aug, 2016


Download ppt "Aug, 2016."

Similar presentations


Ads by Google